コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 neuropathy, myeloproliferative disorder, and monoclonal gammopathy of undetermined significance.
2 ge-progressive premalignant condition termed monoclonal gammopathy of undetermined significance.
3 e marrow myeloma cells, even in asymptomatic monoclonal gammopathy of undetermined significance.
4 apheresis have shown limited efficacy in IgM monoclonal gammopathy of undetermined significance.
5 ltiple myeloma (SMM) bridges the gap between monoclonal gammopathy of undetermined significance (a mo
6 molecular characteristics that evolves from monoclonal gammopathy of undetermined significance, a hi
7 nguish POEMS from neuropathy associated with monoclonal gammopathy of undetermined significance, addi
9 indeterminate potential (CHIP), analogous to monoclonal gammopathy of undetermined significance and m
10 ping phenotypic profiles between AL and both monoclonal gammopathy of undetermined significance and M
11 h light chain amyloidosis, multiple myeloma, monoclonal gammopathy of undetermined significance, and
12 progression from the non-malignant disorder monoclonal gammopathy of undetermined significance, are
13 attern of bone marrow involvement similar to monoclonal gammopathy of undetermined significance at di
15 34 patients with WM and 10 patients with IgM monoclonal gammopathy of undetermined significance (IgM
16 amples from 58 patients with WM, 77 with IgM monoclonal gammopathy of undetermined significance (IgM-
17 ight chain amyloidosis, multiple myeloma and monoclonal gammopathy of undetermined significance, immu
18 y modified paraprotein target (paratargs) in monoclonal gammopathies of undetermined significance (MG
19 l population can be identified as in myeloma/monoclonal gammopathies of undetermined significance (MG
20 Monoclonal gammopathy of undetermined significance (MGUS
21 Monoclonal gammopathy of undetermined significance (MGUS
22 olves from a premalignant condition known as monoclonal gammopathy of undetermined significance (MGUS
23 ewly diagnosed multiple myeloma (MM), 5 with monoclonal gammopathy of undetermined significance (MGUS
24 arises from a common benign PC tumor called Monoclonal Gammopathy of Undetermined Significance (MGUS
25 al similarities to multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS
26 V-8 may play a role in the transformation of monoclonal gammopathy of undetermined significance (MGUS
27 ifferentially expressed in plasma cells from monoclonal gammopathy of undetermined significance (MGUS
28 ic cells from two out of eight patients with monoclonal gammopathy of undetermined significance (MGUS
29 e multiple myeloma to a benign form known as monoclonal gammopathy of undetermined significance (MGUS
30 g clonal cells in the blood of patients with monoclonal gammopathy of undetermined significance (MGUS
31 peculated that the clinical progression from monoclonal gammopathy of undetermined significance (MGUS
32 M transformation from immunoglobulin-M (IgM) monoclonal gammopathy of undetermined significance (MGUS
33 of multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance (MGUS
34 n premalignant plasma cell dyscrasia such as monoclonal gammopathy of undetermined significance (MGUS
35 onsistently preceded by the precursor state, monoclonal gammopathy of undetermined significance (MGUS
36 Blood, Farr et al showed that patients with monoclonal gammopathy of undetermined significance (MGUS
37 lonal gammopathy (AMG), classified as either monoclonal gammopathy of undetermined significance (MGUS
38 ressed in bones of a subset of patients with monoclonal gammopathy of undetermined significance (MGUS
39 Monoclonal gammopathy of undetermined significance (MGUS
40 In 728 Swedish cases of monoclonal gammopathy of undetermined significance (MGUS
41 esson et al study the risk of progression of monoclonal gammopathy of undetermined significance (MGUS
42 Patients with monoclonal gammopathy of undetermined significance (MGUS
43 was absent in 90% of immunoglobulin M (IgM) monoclonal gammopathy of undetermined significance (MGUS
44 old woman with AL-amyloidosis secondary to a monoclonal gammopathy of undetermined significance (MGUS
45 Multiple myeloma is consistently preceded by monoclonal gammopathy of undetermined significance (MGUS
46 er in these patients is more consistent with monoclonal gammopathy of undetermined significance (MGUS
47 Monoclonal gammopathy of undetermined significance (MGUS
48 demonstrate an increased fracture risk with monoclonal gammopathy of undetermined significance (MGUS
49 Monoclonal gammopathy of undetermined significance (MGUS
50 the original clone, referred to as secondary monoclonal gammopathy of undetermined significance (MGUS
51 le myeloma (MM) patients (n = 8740) and 5652 monoclonal gammopathy of undetermined significance (MGUS
52 The association of obesity with monoclonal gammopathy of undetermined significance (MGUS
53 istently preceded by the precursor states of monoclonal gammopathy of undetermined significance (MGUS
54 Monoclonal gammopathy of undetermined significance (MGUS
55 (MM) are preceded by precursor states termed monoclonal gammopathy of undetermined significance (MGUS
56 ich evolves from a premalignant stage called monoclonal gammopathy of undetermined significance (MGUS
57 Monoclonal gammopathy of undetermined significance (MGUS
58 Monoclonal gammopathy of undetermined significance (MGUS
59 The transformation from monoclonal gammopathy of undetermined significance (MGUS
60 Monoclonal gammopathy of undetermined significance (MGUS
61 ilial clustering of the precursor condition, monoclonal gammopathy of undetermined significance (MGUS
62 We examined whether monoclonal gammopathy of undetermined significance (MGUS
63 sorting exosomes from multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS
64 pesticide applicators to assess the risk of monoclonal gammopathy of undetermined significance (MGUS
65 IgM monoclonal gammopathy of undetermined significance (MGUS
66 Monoclonal gammopathy of undetermined significance (MGUS
67 in the etiology of multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS
68 e marrow PCs from subjects with MM (n = 16), monoclonal gammopathy of undetermined significance (MGUS
69 ve cases of multiple myeloma, three cases of monoclonal gammopathy of undetermined significance (MGUS
70 The factors that determine progression from monoclonal gammopathy of undetermined significance (MGUS
71 Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS
72 Monoclonal gammopathy of undetermined significance (MGUS
73 The prevalence of monoclonal gammopathy of undetermined significance (MGUS
74 21) in more than 500 untreated patients with monoclonal gammopathy of undetermined significance (MGUS
75 Monoclonal gammopathy of undetermined significance (MGUS
76 thylation is relatively common and occurs in monoclonal gammopathy of undetermined significance (MGUS
77 of bone marrow specimens from patients with monoclonal gammopathy of undetermined significance (MGUS
78 Monoclonal gammopathy of undetermined significance (MGUS
79 studies have reported a higher prevalence of monoclonal gammopathy of undetermined significance (MGUS
80 in 67% of monoclonal gammopathies, including monoclonal gammopathy of undetermined significance (MGUS
81 s of premalignant non-immunoglobulin M (IgM) monoclonal gammopathy of undetermined significance (MGUS
82 ppa or lambda immunoglobulin light chains in monoclonal gammopathy of undetermined significance (MGUS
83 rease in CD4+ CD25+ T cells in patients with monoclonal gammopathy of undetermined significance (MGUS
84 Whether this dichotomy exists in monoclonal gammopathy of undetermined significance (MGUS
85 d for multiple myeloma (MM) and premalignant monoclonal gammopathy of undetermined significance (MGUS
86 receptors on plasma cells from patients with monoclonal gammopathy of undetermined significance (MGUS
87 ed in the early pathogenesis of premalignant monoclonal gammopathy of undetermined significance (MGUS
88 The events leading the transformation of the monoclonal gammopathy of undetermined significance (MGUS
89 At diagnosis, most patients had monoclonal gammopathy of undetermined significance (MGUS
90 ression was detected in 5 of 5 patients with monoclonal gammopathy of undetermined significance (MGUS
91 been made to quantitate adverse outcomes of monoclonal gammopathy of undetermined significance (MGUS
92 A monoclonal gammopathy of undetermined significance (MGUS
93 previously untreated active myeloma, 14 had monoclonal gammopathy of undetermined significance (MGUS
94 Unlike monoclonal gammopathy of undetermined significance (MGUS
95 omal aberrations have been identified in the monoclonal gammopathy of undetermined significance (MGUS
96 plasma cells (B cells, normal plasma cells, monoclonal gammopathy of undetermined significance [MGUS
97 with the marrow in preneoplastic gammopathy (monoclonal gammopathy of undetermined significance [MGUS
98 those from healthy donors and patients with monoclonal gammopathy of undetermined significance or ot
99 icroenvironment cells in transformation from monoclonal gammopathy of undetermined significance or sm
100 nce interval [CI], 1.31-17.86; P = .018) and monoclonal gammopathy of undetermined significance (OR,
102 ecreased serum adiponectin concentrations in monoclonal gammopathy of undetermined significance patie
103 evidence of paraproteinemia in a setting of monoclonal gammopathy of undetermined significance, smol
104 er than in plasma cells from healthy donors, monoclonal gammopathy of undetermined significance, smol
105 ong 5652 patients with IgG/IgA (but not IgM) monoclonal gammopathy of undetermined significance, supp
106 in a pattern that parallels progression from monoclonal gammopathy of undetermined significance to MM
107 from 61 patients (29 AL, 23 MM, and 9 MGUS [monoclonal gammopathies of undetermined significance]) w
110 n biomarkers can help identify patients with monoclonal gammopathy of undetermined significance who a
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。